Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
08/2004
08/19/2004WO2003049702A8 Vanilloid receptor ligands and their use in treatments
08/19/2004US20040162427 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands
08/19/2004US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease
08/19/2004US20040162331 Heterocylic amines used as antidiabetic or hyperglycemic agents
08/19/2004US20040162324 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments
08/19/2004US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/19/2004US20040162319 For prophylaxis and therapy of thrombotic conditions including coronary artery and cerebrovascular diseases
08/19/2004US20040162318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases
08/19/2004US20040162311 Benzimidazole derivative
08/19/2004US20040162303 4-aminopyrimidine-5-one derivatives
08/19/2004US20040162290 For therapy of cancer, benign prostatic hypertrophy or myoma of the uterus, endometriosis, polycystic ovarian disease, uterine fibroids or precocious puberty, lupus erythematosis, irritable bowel syndrome, premenstrual syndrome, hirsutism
08/19/2004US20040162287 Substituted cyclohexane-1,4-diamine compounds
08/19/2004US20040162282 Substituted piperazines
08/19/2004US20040162276 Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology
08/19/2004US20040162221 Pyrazole derivatives and herbicides containing the same
08/19/2004US20040159265 Transition metal or silicon matrix in which particles of an organic pigment are homogeneously embedded or crosslinked; 3-methylidene-2,3-dihydro-indol-2-ones, quinacridone, indigo, diketopyrrolopyrrole, anthraquinone, perylene; thermostable
08/19/2004DE10304870A1 Triazolverbindungen und ihre therapeutische Verwendung Triazole compounds and their therapeutic use
08/19/2004CA2515516A1 Carboxylic acid compounds
08/19/2004CA2515027A1 Metal ion chelators and therapeutic use thereof
08/19/2004CA2514940A1 Quinoline-derived amide modulators of vanilloid vr1 receptor
08/19/2004CA2513109A1 Mercaptoimidazoles as ccr2 receptor antagonists
08/19/2004CA2512915A1 4-aminopyrimidine-5-one
08/18/2004EP1447405A1 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors
08/18/2004EP1447402A1 Quinoline compound
08/18/2004EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
08/18/2004EP1447399A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses"
08/18/2004EP1446392A1 Oligopeptides and compositions containing them as cathepsin s inhibitors
08/18/2004EP1446387A1 Substituted aryl 1,4-pyrazine derivatives
08/18/2004EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists
08/18/2004EP1446116A1 Inhibitors of dipeptidyl peptidase iv
08/18/2004EP1175397B1 3,3-substituted indoline derivatives
08/18/2004EP0876345B1 Heterocyclic compounds as h+-atpases
08/18/2004EP0619813B1 Linked cyclic polyamines with activity against hiv
08/18/2004CN1522250A Cyclic diamine compound having five-membered cyclic group
08/18/2004CN1522249A Quinoline derivatives as ligands for the neuropeptide y receptor
08/18/2004CN1522246A Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (MTP) and/or apolipoprotein b (APO B) secretion
08/18/2004CN1522245A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes
08/18/2004CN1521165A Thiophene derivative
08/18/2004CN1162426C Thienylalkylamino-1,3-5-triazines and the use thereof as herbicides
08/17/2004US6777437 Antidepressants, anxiolytic agents. sexual disorders
08/17/2004US6777428 Inhibit peptide extravasation due to stimulation of the trigeminal ganglia, and are therefore useful for the treatment of migraine and associated disorders
08/17/2004US6777425 Which binds nucleic acids/dna; gene expression; genetic engineering
08/17/2004US6777424 Administering to a patient having or at risk of having osteoarthritis, a therapeutically effective amount of an bicyclicaromatic or heteroaromatic compound containing amine and hydroxy groups
08/17/2004US6777418 For treating or preventing emphysema, cancer and dermatological disorders
08/17/2004US6777412 Fungicides
08/12/2004WO2004067533A1 Conducting polymers with porphyrin cross-linkers
08/12/2004WO2004067529A1 Indole-derivative modulators of steroid hormone nuclear receptors
08/12/2004WO2004067527A1 Thiophene derivatives as microbicides and herbicides
08/12/2004WO2004067524A1 Ep4 receptor antagonists
08/12/2004WO2004067516A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
08/12/2004WO2004067510A1 3,6-disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
08/12/2004WO2004066950A2 Quinoline derivatives as nk-2 and nk-3 receptor antagonists
08/12/2004WO2004056799A3 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
08/12/2004WO2004056779A3 Tetrahydroquinoline derivatives and their use as fsh receptor modulators
08/12/2004WO2004052878A3 Crystalline derivative of 2- (5-chlorothien-2-yl)-n- ((3s)-1((1s)-1-methyl-2-morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl) ethensulfonamide
08/12/2004WO2004048368A3 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors
08/12/2004WO2004046162A3 Non-steroidal fxr agonists
08/12/2004WO2004032908A3 Method of inhibiting angiogenesis
08/12/2004WO2004032871A3 Piperazine and piperazinone inhibitors of factor xa
08/12/2004WO2003093231A3 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
08/12/2004WO2003092374A3 Pesticidal heterocycles
08/12/2004US20040158064 Prostaglandin endoperoxide H synthase biosynthesis inhibitors
08/12/2004US20040157966 Heat and oxidation resistance; photostability for polymers
08/12/2004US20040157915 Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
08/12/2004US20040157914 Pyrrolidinone derivatives
08/12/2004US20040157907 Insulin resistance; central nervous system disorders; vision disorders; hypoglycemic agents; anticholesterol agents; hypotensive agents; antilipemic agents; anticholesterol agents; tissue antiischemic agents
08/12/2004US20040157901 Vision defects; reducing pressure in eyes
08/12/2004US20040157894 Thiol compounds, their production and use
08/12/2004US20040157893 Pyrazole compounds useful as protein kinase inhibitors
08/12/2004US20040157892 Insecticides; miticides
08/12/2004US20040157890 Dyslipidemia; cardiovascular disorders; antidiabetic agents; eating disorders; antiinflammatory agents; anticholesterol agents
08/12/2004US20040157883 Imidazolamino compounds
08/12/2004US20040157866 Amide compounds
08/12/2004US20040157865 exhibit activity in animal models of hyperalgesia and colitis, and are useful for the treatment and prevention of pain conditions in humans including arthritis, and for the treatment of irritable-bowel syndrome
08/12/2004US20040157862 estrogen agonist/antagonist is (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydronaphthalene-2-ol; A kit for use by a consumer to treat osteoarthritis, the kit comprising: estrogen agonist/antagonist; COX-2 inhibitor
08/12/2004US20040157854 CCRS antagonists useful for treating aids
08/12/2004US20040157850 Novel heterocyclic derivatives
08/12/2004US20040157844 6-azauracil derivatives as thyroid receptor ligands
08/12/2004US20040157829 useful in the treatment of central or peripheral nervous system disorders(e.g., migraine, ataxia, Parkinson's disease, bipolar disorders, epilepsy, hearing and vision loss, Alzheimer's disease, etc.) and as neuroprotective agent
08/12/2004US20040157828 Protease inhibitors
08/12/2004US20040157823 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
08/12/2004US20040157818 antagonism to chemokine receptor CXCR4 for treatment of rheumatism or cancer metastasis
08/12/2004US20040156869 Also 2-substituted quinolines, isoquinolines, pyridoquinolines, pyridoisoquinolines, and pyridoquinazolines; treatment of conditions responsive to capsaicin receptor modulation, especially various kinds of pain
08/12/2004DE4029565B4 Elektrophotographisches Aufzeichnungsmaterial und elektrophotographischer Druckplattenvorläufer, die ein Phthalocyaninpigment und ein Thiobarbitursäurederivat enthalten An electrophotographic recording material and electrophotographic printing plate precursor containing a phthalocyanine pigment and a thiobarbituric acid derivative
08/12/2004DE10255984A1 New 2-aminopyrimidine derivatives are cyclin-dependent kinase inhibitors useful for treating e.g. cancer, autoimmune diseases, cardiovascular diseases, infectious diseases or viral infections
08/12/2004CA2514612A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
08/12/2004CA2511806A1 Indole-derivative modulators of steroid hormone nuclear receptors
08/11/2004EP1445258A1 Activator for peroxisome proliferator-activated receptor delta
08/11/2004EP1445253A1 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof
08/11/2004EP1445252A1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
08/11/2004EP1445250A1 Novel amine derivative having human beta-tryptase inhibitory activity and drugs containing the same
08/11/2004EP1445249A1 Novel bensophenone derivatives or salts thereof
08/11/2004EP1444224A2 3-substituted oxindole beta-3 agonists
08/11/2004EP1444223A1 Aminopyrimidines and -pyridines
08/11/2004EP1444219A1 Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
08/11/2004EP1444211A2 Quinazoline derivatives as antitumor agents
08/11/2004EP1444210A1 Qunazoline derivatives as antitumor agents
08/11/2004EP1444207A2 Substituted pyrazolyl-compounds for the treatment of inflammation
08/11/2004EP1444203A1 Cannabinoid receptor ligands
08/11/2004EP1444201A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors